MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Syndrome of dystonia-parkinsonism is a complication of cyclosporine A treatment and may be irreversible

    P. Miklavcic, S. Avcin, J. Jazbec, T. Vipotnik Vesnaver, B. Todorova, M. Trost, M. Kojovic (Ljubljana, Slovenia)

    Objective: To describe the clinical and imaging features of patients who developed dystonia-parkinsonism syndrome due to cyclosporine A(CsA). Background: CsA is an immunosuppressant widely used…
  • 2016 International Congress

    Psychogenic gait disorders in children – Report of 2 cases

    S. Lorenzl, M. Kranz (Hausham, Germany)

    Objective: To present 2 cases of psychogenic gait disorder in children. Background: Psychogenic movement disorders are up to almost 5 % of patients presenting at…
  • 2016 International Congress

    Home care program for patients with Parkinson’s disease – A Singapore experience

    H.L. Ng, W. Li, S. Abdul Karim, K.Y. Tay, W.L. Au, L.C.S. Tan (Singapore, Singapore)

    Objective: To review the disease profile of patients who were enrolled in the Home Care Program and evaluate the outcomes of the program. Background: With…
  • 2016 International Congress

    Aquatic physical therapy: Functional motor skills in people with Parkinson’s disease

    V.L. Israel, B. Yamaguchi, V.L. Israel (Curitiba, Brazil)

    Objective: Evaluate aquatic motor skills and the terrestrial environment after a aquatic physical therapy (APT) program for people with Parkinson's disease (PD). Background: PD is…
  • 2016 International Congress

    Factors affecting the cardiac sympathetic denervation in autopsy confirmed dementia with Lewy bodies

    M. Takahashi, T. Uchihara, M. Yoshida, K. Wakabayashi, A. Kakita, H. Takahashi, S. Toru, T. Kobayashi, S. Orimo (Tokyo, Japan)

    Objective: To examine the relation among degeneration of the cardiac sympathetic nerve (CSN), clinical features and neuropathological findings in dementia with Lewy bodies (DLB). Background:…
  • 2016 International Congress

    A heterozygous splicing mutation c.823-10G>T at the intron9/exon 10 of the MAPT gene in an Irish family with FTDP- 17

    E.M. Fallon, D.A. Olszewska, C. McGuigan, I. Delon, F. Brett, B. Lawlor, M. Hutchinson, M. Hutton, T. Lynch (Dublin, Ireland)

    Objective: *Authors EMF and DAO contributed equally. To describe the phenotype of the second reported pedigree with the heterozygous splicing mutation c.823-10G>T at the intron…
  • 2016 International Congress

    Differences in physicians’ understanding of biologic and biosimilar medicines in the USA and Europe

    A.L. Molinari, H.L. Gewanter, M. Reilly, D. Charles (Washington, DC, USA)

    Objective: To evaluate differences in physicians' understanding of biologic and biosimilar medicines in the USA and Europe. Background: Biologic medicines, such as botulinum toxins and…
  • 2016 International Congress

    Curcumin supplementation improves motor dysfunction in lipopolysaccharide induced Parkinon’s disease model: Possible biochemical, neurochemical and immunohistochemical alterations in rats

    N. Sharma, B. Nehru (Chandigarh, India)

    Objective: In the present study potential neuroprotective effects of curcumin were tested to determine if they could help to minimize microglia–mediated damage in single intranigral…
  • 2016 International Congress

    AntiParkinsonian effects of the “radiprodil and tozadenant” combination in MPTP-treated marmosets

    A. Michel, J.M. Nicolas, S. Rose, M. Jackson, P. Colman, W. Briône, D. Sciberras, P. Muglia, D. Scheller, M. Citron, P. Downey (Braine L'Alleud, Belgium)

    Objective: Investigate a combination of two clinically tested drugs, the NR2B antagonist Radiprodil and the A2A antagonist Tozadenant in unilaterally 6-OHDA-lesioned rats and in MPTP-treated…
  • 2016 International Congress

    Engrailed enhances dopamine synthesis in healthy dopaminergic neurons

    D. Alvarez-Fischer, M. Baaske, F. Vulinovic, J. Fuchs, P. Seibler, A. Rakovic, A. Prochiantz, C. Klein (Lübeck, Germany)

    Objective: The aim of the present study was to further elucidate the role of Engrailed in dopamine neurotransmission. Background: Engrailed1 and Engrailed2, collectively Engrailed, are…
  • « Previous Page
  • 1
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley